1. Home
  2. OAKU vs AFMD Comparison

OAKU vs AFMD Comparison

Compare OAKU & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OAKU
  • AFMD
  • Stock Information
  • Founded
  • OAKU 2022
  • AFMD 2000
  • Country
  • OAKU Canada
  • AFMD Germany
  • Employees
  • OAKU N/A
  • AFMD N/A
  • Industry
  • OAKU Blank Checks
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • OAKU Finance
  • AFMD Health Care
  • Exchange
  • OAKU Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • OAKU 84.3M
  • AFMD 53.3M
  • IPO Year
  • OAKU 2023
  • AFMD 2014
  • Fundamental
  • Price
  • OAKU $11.20
  • AFMD $3.36
  • Analyst Decision
  • OAKU
  • AFMD Strong Buy
  • Analyst Count
  • OAKU 0
  • AFMD 5
  • Target Price
  • OAKU N/A
  • AFMD $16.25
  • AVG Volume (30 Days)
  • OAKU 5.8K
  • AFMD 80.0K
  • Earning Date
  • OAKU 01-01-0001
  • AFMD 11-12-2024
  • Dividend Yield
  • OAKU N/A
  • AFMD N/A
  • EPS Growth
  • OAKU N/A
  • AFMD N/A
  • EPS
  • OAKU 0.10
  • AFMD N/A
  • Revenue
  • OAKU N/A
  • AFMD $7,959,927.00
  • Revenue This Year
  • OAKU N/A
  • AFMD N/A
  • Revenue Next Year
  • OAKU N/A
  • AFMD $48.98
  • P/E Ratio
  • OAKU $116.90
  • AFMD N/A
  • Revenue Growth
  • OAKU N/A
  • AFMD N/A
  • 52 Week Low
  • OAKU $10.45
  • AFMD $2.92
  • 52 Week High
  • OAKU $11.22
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • OAKU 70.55
  • AFMD 44.84
  • Support Level
  • OAKU $10.98
  • AFMD $3.28
  • Resistance Level
  • OAKU $11.22
  • AFMD $3.51
  • Average True Range (ATR)
  • OAKU 0.00
  • AFMD 0.17
  • MACD
  • OAKU -0.00
  • AFMD 0.04
  • Stochastic Oscillator
  • OAKU 71.43
  • AFMD 55.79

About OAKU Oak Woods Acquisition Corporation

Oak Woods Acquisition Corp is a a newly-incorporated blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more target businesses.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: